Autism Impact Fund

Unison Therapy Services specializes in providing Applied Behavior Analysis (ABA) therapy for children with autism and developmental disabilities. The organization focuses on family-centered therapeutic interventions and operates in various settings, including clinics, homes, and schools, across California and Colorado. By prioritizing the needs of families, Unison aims to create supportive and effective treatment environments that enhance the well-being and development of children with special needs.

Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

SpectrumAi is a digital health company focused on enhancing Autism care by increasing access to high-quality Applied Behavior Analysis (ABA) therapy for children globally. The company collaborates with clinical leaders in ABA therapy, parents, and payers to modernize treatment approaches. SpectrumAi's healthcare technology offers objective data and meaningful insights, providing actionable guidance that empowers patients to work towards independent living, meaningful relationships, lifelong vocation, and self-advocacy. Through its innovative solutions, SpectrumAi aims to provide alternatives for life-changing therapies, ultimately improving outcomes for individuals on the autism spectrum.

Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. It specializes in connecting mental health therapists with children and adults through an online platform that facilitates video calling. Healios provides a clinician-led online family intervention service, which includes interactive psychoeducation for family members and caregivers of individuals affected by mental illness. By integrating advanced technology with clinical expertise and a personal touch, Healios aims to empower patients and their families, helping them understand mental health challenges and adopt healthier habits. The company's mission is to enhance the delivery of care, enabling patients, families, and caregivers to achieve their goals and improve their quality of life.

Floreo Inc., founded in 2016 and based in Washington D.C., develops a virtual reality learning app designed to teach social and communication skills to individuals with autism spectrum disorder, as well as those with ADHD and anxiety. The platform allows supervising adults to monitor and guide activities, making it a valuable tool for therapy clinics and school districts. Floreo is used by over 100 therapy clinic businesses and school districts, and has partnered with Meta to expand its reach in public schools.

SpectrumAi is a digital health company focused on enhancing Autism care by increasing access to high-quality Applied Behavior Analysis (ABA) therapy for children globally. The company collaborates with clinical leaders in ABA therapy, parents, and payers to modernize treatment approaches. SpectrumAi's healthcare technology offers objective data and meaningful insights, providing actionable guidance that empowers patients to work towards independent living, meaningful relationships, lifelong vocation, and self-advocacy. Through its innovative solutions, SpectrumAi aims to provide alternatives for life-changing therapies, ultimately improving outcomes for individuals on the autism spectrum.

Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

auticon GmbH is a consulting firm based in Berlin, Germany, with additional offices in Munich and Düsseldorf. Founded in 2011, the company specializes in information technology services, particularly in software testing and quality assurance. auticon employs autistic individuals exclusively as software testers, leveraging their unique skills to provide high-quality workmanship in various areas, including static code analysis, functional testing, usability testing, and data analysis. The company's services cater to a diverse clientele, including software producers, IT firms, consulting companies, and public institutions. By focusing on the strengths of its workforce, auticon not only delivers exceptional testing services but also promotes inclusivity within the tech industry.

BioROSA Technologies Inc. is a Belmont, Massachusetts-based company focused on developing blood tests for Autism Spectrum Disorders (ASD). Founded in 2018, the company aims to establish a biologically-based standard of care for ASD through innovative diagnostic tools. These tools enable clinicians to identify individuals at risk for ASD by utilizing blood-based biomarkers and advanced machine learning techniques. BioROSA’s platform not only enhances early detection and diagnosis but also supports therapeutic developments by facilitating patient stratification and assessing pharmacodynamics in clinical trials. This comprehensive approach equips healthcare professionals with the necessary resources to improve patient outcomes through timely intervention.

SpectrumAi is a digital health company focused on enhancing Autism care by increasing access to high-quality Applied Behavior Analysis (ABA) therapy for children globally. The company collaborates with clinical leaders in ABA therapy, parents, and payers to modernize treatment approaches. SpectrumAi's healthcare technology offers objective data and meaningful insights, providing actionable guidance that empowers patients to work towards independent living, meaningful relationships, lifelong vocation, and self-advocacy. Through its innovative solutions, SpectrumAi aims to provide alternatives for life-changing therapies, ultimately improving outcomes for individuals on the autism spectrum.

Suggestic, Inc. is a San Francisco-based company founded in 2014 that specializes in automated and personalized lifestyle and nutrition coaching. Its platform leverages proprietary artificial intelligence to create tailored diet plans that cater to users' individual goals, dietary preferences, and restrictions. The application facilitates precision eating by offering personalized meal plans, smart shopping lists, recipe suggestions, and restaurant recommendations. By encoding dietary programs as rulesets, Suggestic enables health-related organizations to efficiently build and deliver customized nutrition programs through white label solutions or direct API integration. The platform also supports data acquisition from users through assessments and lab tests, allowing it to provide relevant food recommendations that assist individuals in weight management, enhancing vitality, and preventing or reversing chronic diseases.

Floreo Inc., founded in 2016 and based in Washington D.C., develops a virtual reality learning app designed to teach social and communication skills to individuals with autism spectrum disorder, as well as those with ADHD and anxiety. The platform allows supervising adults to monitor and guide activities, making it a valuable tool for therapy clinics and school districts. Floreo is used by over 100 therapy clinic businesses and school districts, and has partnered with Meta to expand its reach in public schools.

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapies for Autism Spectrum Disorder (ASD). The company is advancing L1-79, a novel oral treatment designed to improve the core symptoms associated with ASD. This therapy targets both central nervous system and metabolic symptoms, aiming to modulate catecholaminergic pathways. By addressing these pathways, Yamo Pharmaceuticals seeks to enhance socialization and communication skills in individuals with Autism, providing a therapeutic option that directly confronts the challenges faced by those affected by the disorder.

Axial Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for central nervous system diseases and disorders. Based in Waltham, Massachusetts, the company utilizes a microbiome discovery platform that targets the gut-brain axis, allowing for the exploration and creation of innovative therapies aimed at improving the quality of life for patients suffering from neurological conditions. Incorporated in 2013, Axial Biotherapeutics seeks to advance its pipeline of novel treatments to address the unmet needs in the field of CNS disorders.

Joshin, LLC is a company based in Shoreview, Minnesota, that specializes in developing software applications focused on disability care. Its primary product is the Joshin application, which connects families with caregivers who are experienced, qualified, and screened to support individuals with disabilities and neurodivergence. The platform allows users to create personalized care plans that detail the needs, goals, preferences, and dietary requirements of their loved ones, facilitating a tailored approach to care. In addition to connecting families with caregivers, Joshin provides virtual coaching and education on disability issues, guiding families in navigating the complexities of care for individuals with special needs.

MARABio is a biotechnology company focused on the detection and prevention of severe forms of Autism Spectrum Disorder (ASD). The firm specializes in maternal autoantibody-related autism testing, which assesses the risk of ASD by identifying a unique cluster of antibodies in mothers that target proteins in the developing brains of their children. This licensed technology allows for early intervention, enabling mothers to initiate targeted behavioral therapies if their children show signs of developmental delay. By providing critical insights into the maternal health factors associated with autism, MARABio aims to improve outcomes for children at risk for ASD.